These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3609505)

  • 1. Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy.
    Actis GC; Maran E; Rosina F; Saracco G; Rocca G; Rizzetto M; Bonino F; Verme G
    Digestion; 1987; 37(1):51-8. PubMed ID: 3609505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response.
    Actis GC; Maran E; Bonino F; Saracco G; Rosina F; Brunetto MR; Baldi M; Rizzetto M; Verme G; Rocca B
    J Biol Regul Homeost Agents; 1987; 1(1):45-50. PubMed ID: 2461050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriers.
    Actis GC; Maran E; Saracco G; Rosina F; Brunetto MR; Baldi M; Lattore V; Rocca G; Bonino F; Rizzetto M
    Ric Clin Lab; 1987; 17(4):331-41. PubMed ID: 3438668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
    J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
    J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
    Rizzetto M; Rosina F; Saracco G; Bellando PC; Actis GC; Bonino F; Smedile A; Trinchero P; Sansalvadore F; Pintus C
    J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low dosage of interferon on natural killer activity in patients with HBsAg-positive chronic active hepatitis.
    Matsumura N; Yoshikawa T; Kondo M; Imanishi J; Kishida T
    Digestion; 1984; 30(4):195-9. PubMed ID: 6510570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 16. [The problem of the interferon therapy of patients with chronic viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):101-4. PubMed ID: 8525715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte alpha-A interferon.
    Hess G; Gerlich W; Slusarczyk J; Hütteroth TH; Meyer zum Büschenfelde KH
    J Hepatol; 1986; 3 Suppl 2():S245-51. PubMed ID: 3598157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha interferon plus thymopentine in treatment of HBV and/or HDV positive patients undergoing liver transplant.
    Gaeta A; Mancini C; Bachetoni A; Sallusto F; Lorino G; Marinucci G; Di Giacomo C; Favalli C; Alfani D; Filadoro F
    J Biol Regul Homeost Agents; 1990; 4(2):51-6. PubMed ID: 2260503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.